Condition: Paroxysmal Atrial Fibrillation · Sponsor: Boston Scientific Corporation
To collect clinical data on safety, effectiveness and procedural success of Boston Scientific's Cardiac Cryoablation System (includes all BSC commercially available POLARx/POLARx Fit catheters) when used to perform pulmonary vein isolation (PVI) in the ablation treatment of de novo Atrial Fibrillation (AF).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Mercy Gilbert Medical Center | Gilbert, Arizona, United States | — |
| Banner University Medical Center Phoenix | Phoenix, Arizona, United States | — |
| Pima Heart & Vascular Clinical Research | Tucson, Arizona, United States | — |
| Torrance Memorial Medical Center | Torrance, California, United States | — |
| Intermountain Platte Valley Hospital | Brighton, Colorado, United States | — |
| Valley View Hospital | Glenwood Springs, Colorado, United States | — |
| St. Joseph's Hospital/BayCare Medical Group | Tampa, Florida, United States | — |
| Bethesda North Hospital | Cincinnati, Ohio, United States | — |
| Prisma Health Richland Hospital | Columbia, South Carolina, United States | — |
| University of Texas Medical Branch - Galveston | Galveston, Texas, United States | — |
| Aurora Health | Grafton, Wisconsin, United States | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.